(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 7.96% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.3%.
Caredx's revenue in 2026 is $458,089,000.On average, 10 Wall Street analysts forecast CDNA's revenue for 2026 to be $25,608,957,727, with the lowest CDNA revenue forecast at $23,007,243,653, and the highest CDNA revenue forecast at $26,927,145,729. On average, 10 Wall Street analysts forecast CDNA's revenue for 2027 to be $27,403,617,923, with the lowest CDNA revenue forecast at $24,473,391,532, and the highest CDNA revenue forecast at $29,496,267,243.
In 2028, CDNA is forecast to generate $29,928,248,006 in revenue, with the lowest revenue forecast at $27,394,305,763 and the highest revenue forecast at $33,554,299,696.